AI assistant
Novonesis AS Share Issue/Capital Change 2021
3377_rns_2021-04-12_c1a535bb-8b4c-40b1-8853-5996840f4f29.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Reduction of share capital
In reference to company announcement no. 12/2021, Novozymes has now registered the final implementation of the reduction of its shares with the Danish Business Authority. The nominal value of the reduction is DKK 6,000,000 equaling a cancellation of 3,000,000 B shares held in Novozymes' treasury, at a nominal value of DKK 2 each. Consequently, the reduction of Novozymes' B shares from DKK 462,512,800 to DKK 456,512,800 has been completed.
Following the above, and pursuant to Article 32 of the Danish Capital Markets Act, Novozymes hereby announces that its total shares as of today consists of nominally DKK 564,000,000 equaling 282,000,000 shares, divided into 53,743,600 A shares and 228,256,400 B shares with a nominal value of DKK 2 each and a total of 1,531,384,800 voting rights.
April 12, 2021
Company announcement No. 18
Contact information
[email protected]
Tobias Cornelius Björklund
+45 3077 8682
[email protected]
Carl Ahlgren
+1 919 702 6144
[email protected]
Ulrik Wu Svare
+45 3077 3187
[email protected]
| Nominal Value, DKK | Number of shares | |
|---|---|---|
| A shares | 107,487,200 | 53,743,600 |
| B shares | 456,512,800 | 228,256,400 |
| Total | 564,000,000 | 282,000,000 |
On April 12, 2021, following the reduction of its shares, Novozymes held 3,157,061 million B shares in treasury, equivalent to 1.1% of the reduced total share capital.
About Novozymes
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com
Novozymes A/S CVR number: 10 00 71 27 LEI: 52006076WND032R3JW38
Rethink A/S
Rethink Tomorrow
novozymes A/S
Knogshoejej 36
2880 Bagsvaerd
Denmark
Phone: +45 4446 0000